一周之内,两笔跨国大交易,把同一个赛道推到了聚光灯下。2月25日,诺和诺德宣布与麻省理工学院传奇科学家Robert Langer实验室分拆公司Vivtex达成深度合作,交易总额最高达21亿美元,共同开发下一代代谢类药物的口服递送技术。几天前的2月18日,诺华以1亿美元首付款、潜在总金额超17亿美元,与加州生物科技公司Unnatural Products(UNP)签约,押注其AI驱动的大环肽平台,...
Source Link一周之内,两笔跨国大交易,把同一个赛道推到了聚光灯下。2月25日,诺和诺德宣布与麻省理工学院传奇科学家Robert Langer实验室分拆公司Vivtex达成深度合作,交易总额最高达21亿美元,共同开发下一代代谢类药物的口服递送技术。几天前的2月18日,诺华以1亿美元首付款、潜在总金额超17亿美元,与加州生物科技公司Unnatural Products(UNP)签约,押注其AI驱动的大环肽平台,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.